IPLEX and the Telephone Game: The difficulty in separating myth from reality on the internet

被引：5

作者：

Bedlack, Richard S. ^{[1
]}

Silani, Vincenzo ^{[2
,3
]}

Cudkowicz, Merit Ester ^{[4
]}

机构：

[1] Duke Univ, Med Ctr, ALS Clin, Durham, NC 27710 USA

[2] Univ Milan, Milan Med Sch, IRCCS Ist Auxologico Italiano, Dept Neurol, Milan, Italy

[3] Univ Milan, Milan Med Sch, IRCCS Ist Auxologico Italiano, Neurosci Lab, Milan, Italy

[4] Harvard Univ, Sch Med, Mass Gen Hosp, Boston, MA USA

来源：

AMYOTROPHIC LATERAL SCLEROSIS | 2009年 / 10卷 / 03期

关键词：

AMYOTROPHIC-LATERAL-SCLEROSIS; GROWTH-FACTOR-I; ALS; PROGRESSION; TRIAL;

D O I：

10.1080/17482960802673059

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

100204 [神经病学];

摘要：

引用

页码：182 / 184

页数：3

共 12 条

[1]

*AIFA, 2006, INS LIK GROWTH FACT

[2]

*AIFA, 2006, SCLER LAT AM PROSP T

[3]

*AISLA IT, IGF 1 ALS STAT ART

[4]

Scrutinizing enrollment in ALS clinical trials: Room for improvement? [J].

Bedlack, Richard S. ;

Pastula, Daniel ;

Welsh, Emily ;

Pulley, Darlene ;

Cudkowicz, Merit E. .

AMYOTROPHIC LATERAL SCLEROSIS, 2008, 9 (05) :257-265

[5]

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis [J].

Borasio, GD ;

Robberecht, W ;

Leigh, PN ;

Emile, J ;

Guiloff, RJ ;

Jerusalem, F ;

Silani, V ;

Vos, PE ;

Wokke, JHJ ;

Dobbins, T .

NEUROLOGY, 1998, 51 (02) :583-586

[6]

Comis RL., 2000, A Quantitative Survey of Public Attitudes Towards Cancer Clinical Trials

[7]

Lithium delays progression of amyotrophic lateral sclerosis [J].

Fornai, Francesco ;

Longone, Patrizia ;

Cafaro, Luisa ;

Kastsiuchenka, Olga ;

Ferrucci, Michela ;

Manca, Maria Laura ;

Lazzeri, Gloria ;

Spalloni, Alicia ;

Bellio, Natascia ;

Lenzi, Paola ;

Modugno, Nicola ;

Siciliano, Gabriele ;

Isicloro, Ciro ;

Murri, Luigi ;

Ruggieri, Stefano ;

Paparelli, Antonio .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (06) :2052-2057

[8]

Effect of recombinant human insulin-like growth factor-I on progression of ALS - A placebo-controlled study [J].

Lai, EC ;

Felice, KJ ;

Festoff, BW ;

Gawel, MJ ;

Gelinas, DF ;

Kratz, R ;

Murphy, MF ;

Natter, HM ;

Norris, FH ;

Rudnicki, SA .

NEUROLOGY, 1997, 49 (06) :1621-1630

[9]

Patil RR, 2008, CRIT REV THER DRUG, V25, P1

[10]

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial [J].

Sorenson, E. J. ;

Windbank, A. J. ;

Mandrekar, J. N. ;

Bamlet, W. R. ;

Appel, S. H. ;

Armon, C. ;

Barkhaus, P. E. ;

Bosch, P. ;

Boylan, K. ;

David, W. S. ;

Feldman, E. ;

Glass, J. ;

Gutmann, L. ;

Katz, J. ;

King, W. ;

Luciano, C. A. ;

McCluskey, L. F. ;

Nash, S. ;

Newman, D. S. ;

Pascuzzi, R. M. ;

Pioro, E. ;

Sams, L. J. ;

Scelsa, S. ;

Simpson, E. P. ;

Subramony, S. H. ;

Tiryaki, E. ;

Thornton, C. A. .

NEUROLOGY, 2008, 71 (22) :1770-1775

← 1 2 →